Literature DB >> 2112558

Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome.

J Balasch1, F Carmona, J Llach, V Arroyo, I Jové, J A Vanrell.   

Abstract

We report a case of severe ovarian hyperstimulation syndrome which developed in a patient after ovarian stimulation for in-vitro fertilization (IVF). This was complicated by prerenal oliguria due to indomethacin therapy and liver dysfunction. The pathogenetic mechanisms involved are discussed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2112558     DOI： 10.1093/oxfordjournals.humrep.a137103

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

3.  Ovarian hyperstimulation: actual and theoretical risks.

Authors:  B H Smith; I D Cooke
Journal:  BMJ       Date:  1991-01-19

4.  An unusually prolonged course of late onset severe OHSS with successful outcome - a rare but avoidable complication.

Authors:  Neena Malhotra; Anshu Yadav; Chithira Sridhar; Pankush Gupta; Monika Saini
Journal:  JBRA Assist Reprod       Date:  2022-01-17

5.  Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.

Authors:  Jennifer J Chae-Kim; Robert Roman; Kristina Hawkins; Larisa Gavrilova-Jordan
Journal:  Case Rep Womens Health       Date:  2021-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.